Miragen Therapeutics Inc (MGEN) Return on Investment ROI from the second quarter of 2026 to second quarter of 2019 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Dec 31 2019 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Miragen Therapeutics Inc   (NASDAQ: MGEN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Miragen Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Miragen Therapeutics Inc's ROI in the second quarter of 2026?
Miragen Therapeutics Inc recorded a cumulative net loss of $-240 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -59.37%.

Within the Healthcare sector 670 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2025 from 4252 to 4408.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Jun 30 2025)
II. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Dec 31 2019)
IV. Quarter
Y / Y Investment Change TTM 1085.83 % 780.07 % 151.42 % 31996.65 % -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,033 530 25 27 20
Return On Investment (TTM) -59.37 % -81.56 % -132.38 % -127.68 % -122.94 %
MGEN's Overall Ranking # 4408 # 4252 # # #
Seq. Investment Change TTM 168.29 % 498.87 % -12.5 % -15.66 % 99.11 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -240 -123 -33 -37 -42

MGEN Company Profile >> Back to MGEN Roi Comparisons >> See Annual MGEN Return On Investment



Return On Investment MGEN's Ranking
Within: No.
Industry # 28
Sector # 671
Overall # 4408

Return On Investment Statistics
High Average Low
-122.94 %
-7558.79 %
-44325.14 %
(Dec 31 2019)   (Mar 31 2019)







Financial Statements
Miragen Therapeutics Inc's II. Quarter Investments $ 1,033 Millions MGEN's Balance sheet
Miragen Therapeutics Inc's II. Quarter Income $ -127 Millions Quarterly MGEN's Income Statement
MGEN's Income by Division See MGEN's Income by Division


MGEN Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 20 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions -42 -33 -27 -13 -11
Y / Y Net Income Growth - - - - -
Annual Return On Investment -208.51 % - - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MGEN's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MGEN's Competitors
Subscribers only: Roi for Miragen Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for MGEN's Customers

Other Ratios
MGEN's Roa MGEN's Inventory Turnover Ratio MGEN's Growth Rates MGEN's Dividend Statistics
MGEN's Profitability Ratios MGEN's Asset Turnover Ratio MGEN's Dividend Growth
MGEN's Roe MGEN's Valuation Ratios MGEN's Financial Strength Ratios MGEN's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-12T06:14:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.